Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche, Applera win enhanced damages from MJ Research:

This article was originally published in Clinica

Executive Summary

In a patent dispute over polymerase chain reaction (PCR) and thermal cycler technology dating back to 1998, Roche Diagnostics and Applera company Applied Biosystems have been granted enhanced damages from MJ Research, a company that is now owned by Bio-Rad. The district court in Connecticut doubled the damages previously awarded by a jury to the two companies to $35.4m plus attorney fees, saying that MJ Research displayed an exceptional degree of dismissiveness of patent rights and disrespect for the law. It ordered the enhanced damages "to punish this conduct and deter similar behaviour". Antitrust counterclaims by MJ Research were dismissed in December 2004.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT054773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel